146) C-reactive protein levels and leucocyte counts droppe |
147) infection parameters including C-reactive protein levels and leucocyte counts. |
148) Rho monomeric G protein levels are increased in pancreatic |
149) s increase corresponded to the total TSC2 protein levels expressed in cells. |
150) MP-2 and -9 activity, mRNA expression and protein levels in SK-Hep1 cells. |
151) N-cadherin and Vimentin at both mRNA and protein levels in a dose-dependent manner. |
152) SIRT1 regulates Dishevelled (DVL) protein levels in cancer cells, and DVL al |
153) ncreasing CDK4-HSP90 association and CDK4 protein levels in cells. |
154) ulted in a significant decrease in CYP2E1 protein levels in dose-dependent manner. |
155) antly down-regulated at both the mRNA and protein levels in male mice after combined |
156) n of Kdm1a increased at both the mRNA and protein levels in older GV oocytes, but de |
157) Bufalin also suppressed protein levels of FAK and Rho A, VEGF, MEK |
158) CECF decreased protein levels of FAK, PKC, SOS1, MKK7, ME |
159) Moreover, protein levels of activated and total casp |
160) racts from staged embryos showed constant protein levels of both enzymes until the 3 |
161) ing dual-energy x-ray absorptiometry, and protein levels of mitochondrial enzymes de |
162) Modulation of mRNA and protein levels suggested protection agains |
163) story of headache and elevated C-reactive protein levels was admitted for biopsy of |
164) mRNA) expression in the VTA, whereas Ago2 protein levels were decreased and increase |
165) n reduction of Survivin and XIAP mRNA and protein levels. |
166) predicted miRNA targets APAF1 and Beclin1 protein levels. |
167) vates plasma viscosity, despite decreased protein levels. |
168) ferase and cytokeratin-18 at the mRNA and protein levels. |
169) Protein expression levels of cell adhesion |
170) ion activity, focal adhesion kinase (FAK) protein expression and activity, and matri |
171) We have analyzed different protein expression by Western blotting and |
172) was undertaken to evaluate PSPN mRNA and protein expression by analyzing cellular p |
173) s, antioxidant enzymes activity, gene and protein expression by immunoblot assay sho |
174) Furthermore, the PSPN protein expression in 101 primary OSCCs wa |
175) plaque volume and inhibited aortic LOX-1 protein expression in apo E(-/-) mice. |
176) s associated with suppression of vimentin protein expression in vivo. |
177) ts were studied by analyzing the gene and protein expression levels of early germ la |
178) l translation of rodent data, we examined protein expression of 6 NMDAR subunits in |
|